However , only women who were healthier and responded better to conventional chemotherapy were eligible for the Phase II studies .
The researchers proceeded with Phase II trials , which showed very promising results .
Only women who were healthier and responded better to conventional chemotherapy were eligible for the Phase II studies .
The researchers proceeded with Phase II trials , which showed very promising results .